logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Murat Bardakçı

Diyarbakir Gazi Yasargil Training and Research Hospital

3H指数
53论文数
48被引数
收录论文 11
发表时间
logo
Association Between ABO Blood Group and Survival Outcomes in Advanced NSCLC Treated with Immune Checkpoint InhibitorsABO血型与接受免疫检查点抑制剂治疗的晚期非小细胞肺癌患者生存结局的关系
errCurrent Oncology
IF3.4
err2026-10-01
err0
errOAAI
errHilal Karakaş; Safa Can Efil; Burak Bilgin; Mehmet Ali Nahit Şendur; Murat Bardakçı; Perihan Perkin; Yakup Ergun
err分享
err收藏
Comparative Safety Profiles of Sacituzumab Govitecan and Datopotamab Deruxtecan: A Real-World Pharmacovigilance StudySacituzumab Govitecan和Datopotamab Deruxtecan的安全性比较：一项真实世界药物警戒研究
errJournal of Clinical Medicine
IF2.9
err2026-09-23
err0
errOAAI
errZiya Kalkan; Murat Bardakci; Tugba Tezer Kalkan; Yakup Ergun
err分享
err收藏
Pretreatment prognostic nutritional index is associated with survival outcomes in locally advanced NSCLC treated with definitive chemoradiotherapy治疗前预后营养指数与接受根治性化放疗的局部晚期非小细胞肺癌患者的生存结局相关
errScientific Reports
IF3.9
err2026-07-30
err0
errOAAI
errSerdar İleri; Sezai Tunç; Ogur Karhan; Nadiye Akdeniz; Fatma Keskin Uzundere; Mehmet Sıddık Dilek; Tugba Tezer Kalkan; Vahap Özkan; Yasin Sezgin; Halis Yerlikaya; Murat Bardakçı; Zuhat Urakçı
err分享
err收藏
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer低肌肉质量预示晚期卵巢癌对新辅助化疗的不良反应
errJournal of Ovarian Research
IF4.2
err2026-06-16
err0
errOAAI
errDerya Demirtaş Esmer; Emre Hafızoğlu; Murat Bardakçı; Erdem Özkan; Serhat Sekmek; Doğan Bayram; İrfan Karahan; Efnan Algın; Öznur Bal
err分享
err收藏
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study(vol61 , 638 , 2025)免疫疗法与化疗在晚期胸膜间皮瘤中的疗效比较：一项土耳其肿瘤学小组（TOG）研究（vol61，638，2025）
errMEDICINA-LITHUANIA
IF2.4
err2025-11-07
err0
errOAAI
errKalkan, Ziya; Ebinc, Senar; Arcagok, Murat; Bilici, Ahmet; Yildiz, Ozcan; Kilickap, Saadettin; Guven, Deniz Can; Tatli, Ali Murat; Sumbul, Ahmet Taner; Mandel, Nil Molinas; Ozturk, Akin; Bardakci, Murat; Karakaya, Serdar; Kaplan, Muhammet Ali
err分享
err收藏
Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis肛直肠恶性黑色素瘤：单中心回顾性分析的诊疗误区与预后启示
errDiagnostics 2025, Vol. 15, Page 2086
IF3.3
err2025-08-23
err0
PREAI
errEmre Hafızoğlu; Murat Bardakçı; Yakup Ergun; Irfan Karahan; Doğan Bayram; Fahriye Tugba Kos; Efnan Algın; Oznur Bal; Dogan Uncu
err分享
err收藏
Efficacy and safety of omitting 5-fluorouracil bolus in combination chemotherapy regimens for gastrointestinal cancers: a systematic review and meta-analysis省略5-氟尿嘧啶推注在胃肠道癌症联合化疗方案中的有效性与安全性：一项系统评价和Meta分析
errExpert Opinion on Drug Safety
IF3.1
err2025-07-02
err0
PREAI
errYusuf Ilhan; Onur Yazdan Balcık; Elif Sahın; Aysegul Merc Cetınkaya; Elvina Almuradova; Murat Bardakcı; Cigdem Dınckal; Murat Karateke; Kadriye Bır Yucel; Arif Hakan Onder; Yakup Ergun
err分享
err收藏
The effect of an interactive nurse support program developed with a mobile application on patient outcomes in breast cancer patients who received outpatient chemotherapy: A randomized controlled trial使用移动应用程序开发的互动式护士支持项目对接受门诊化疗的乳腺癌患者结局的影响：一项随机对照试验
errEuropean Journal of Oncology Nursing
IF2.7
err2025-03-25
err0
PREAI
errHandan Özdemir; Ayten Demir; Murat Bardakçı; Doğan Uncu
err分享
err收藏
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
errSCIENTIFIC REPORTS
IF3.9
err2024-05-09
err0
errOAAI
errBardakci, Murat; Karakas, Hilal; Bayram, Dogan; Avci, Nilufer; Kitapli, Sait; Ozen, Mirac; Aslan, Ferit; Koseoglu, Caglar; Kadioglu, Ahmet; Onur, Ilknur D.; Sakalar, Teoman; Buyuksimsek, Mahmut; Alkan, Ali; Ergun, Yakup; Kaya, Ali O.; Bilgin, Burak; Yalcin, Bulent
err分享
err收藏
Efficacy of postoperative radiotherapy (PORT) in stage IIIA-N2 non-small cell lung cancer: Meta-analysis of randomized controlled studies
errANNALS OF ONCOLOGY
IF65.4
err2022-04-01
err0
errOAAI
errErgun, Y.; Ucar, G.; Acikgoz, Y.; Dirikoc, M.; Esen, S. Akturk; Bardakci, M.; Karacin, C.; Uncu, D.
err分享
err收藏
Efficacy and safety of Anti-EGFR TKIs combined with bevacizumab or ramucirumab in the first-line treatment of non-small cell lung cancer: Meta-analysis of randomized controlled trials
errANNALS OF ONCOLOGY
IF65.4
err2021-09-01
err0
errOAAI
errErgun, Y.; Ucar, G.; Acikgoz, Y.; Dirikoc, M.; Esen, S. Akturk; Bardakci, M.; Uncu, D.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Saadettin Kılıçkap
H 指数: 31 · 论文数: 465
A
Ahmet Bılıcı
H 指数: 26 · 论文数: 376
D
Deniz Can Güven
H 指数: 25 · 论文数: 311
B
Bülent Yalçın
H 指数: 24 · 论文数: 297
N
Nil Molinas Mandel
H 指数: 20 · 论文数: 148
查看更多